3.4.25.1	19S regulatory complex	represents the major proteasome activator	712918	
3.4.25.1	19S regulatory particle	-	688337	
3.4.25.1	3H-1,2-dithiole-3-thione	tissue specific increase of the catalytic subunits of the proteasome following oral administration of 0.5 mmol/kg	688760	
3.4.25.1	aflatoxin G1	specific stimulator of activity	685443	
3.4.25.1	Blm10 protein	-	688337	
3.4.25.1	chymostatin	0.05 mg/ml, activation to 170% of the original activity, peptidyl-glutamyl-peptide-hydrolyzing activity, hydrolysis of benzyloxycarbonyl-LLE-2-naphthylamide	649428	
3.4.25.1	doxorubicin	apoptosis inductor doxorubicin increases enzymatic activities, regulates subunit composition, and phosphorylation state of 26S proteasomes	685994	
3.4.25.1	histone H3	slective activation of the branched-chain amino acid preferring activity with benzyloxycarbonyl-GPALG-4-aminobenzoate as substrate, 1000%	650040	
3.4.25.1	KYFTGSKLWRSYYA	peptidic activator, based on the Blm10 activator of 20S proteasome. At 10 microM concentration, chymotrypsin-like and peptidylglutamyl peptide hydrolyzing activities increase around three times whereas trypsin-like activity increases around 7fold	755477	
3.4.25.1	leupeptin	0.05 mg/ml, activation to 125% of the original activity, peptidyl-glutamyl-peptide-hydrolyzing activity, hydrolysis of benzyloxycarbonyl-LLE-2-naphthylamide	649428